A detailed history of Corient Capital Partners, LLC transactions in Alcon Inc stock. As of the latest transaction made, Corient Capital Partners, LLC holds 6,786 shares of ALC stock, worth $641,412. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,786
Previous 6,786 -0.0%
Holding current value
$641,412
Previous $474,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$64.25 - $81.25 $49,729 - $62,887
-774 Reduced 10.24%
6,786 $474,000
Q1 2022

May 16, 2022

SELL
$71.65 - $87.13 $1,146 - $1,394
-16 Reduced 0.21%
7,560 $600,000
Q4 2021

Feb 11, 2022

SELL
$77.91 - $88.5 $298,473 - $339,043
-3,831 Reduced 33.58%
7,576 $660,000
Q3 2021

Nov 16, 2021

BUY
$68.18 - $87.25 $2,931 - $3,751
43 Added 0.38%
11,407 $918,000
Q2 2021

Aug 16, 2021

BUY
$66.27 - $76.21 $24,917 - $28,654
376 Added 3.42%
11,364 $798,000
Q1 2021

May 17, 2021

BUY
$65.32 - $76.01 $24,952 - $29,035
382 Added 3.6%
10,988 $771,000
Q4 2020

Feb 12, 2021

SELL
$56.82 - $66.57 $4,431 - $5,192
-78 Reduced 0.73%
10,606 $700,000
Q3 2020

Nov 16, 2020

SELL
$55.23 - $62.39 $24,025 - $27,139
-435 Reduced 3.91%
10,684 $608,000
Q2 2020

Aug 14, 2020

SELL
$49.45 - $64.16 $12,807 - $16,617
-259 Reduced 2.28%
11,119 $637,000
Q1 2020

May 06, 2020

BUY
$39.86 - $63.46 $65,051 - $103,566
1,632 Added 16.75%
11,378 $578,000
Q4 2019

Feb 04, 2020

SELL
$55.04 - $59.27 $52,893 - $56,958
-961 Reduced 8.98%
9,746 $552,000
Q3 2019

Nov 06, 2019

SELL
$58.2 - $62.42 $17,227 - $18,476
-296 Reduced 2.69%
10,707 $624,000
Q2 2019

Aug 08, 2019

BUY
$54.43 - $63.33 $598,893 - $696,819
11,003 New
11,003 $683,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $46.3B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.